Sosei Group has a broad product pipeline which has been primarily established through in-licensing and in-house product discovery which comprises two elements. In-licensing: In-licensing Japan rights for established or late-stage development products. Sosei's Product Discovery - new uses for marketed drugs and marketed drug templates and - new uses for drugs that have stalled in development.